mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.001 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |